B O O K - American College of Rheumatology

THURSDAY, NOVEMBER 11, 2010
ACR/ARHP Registration
6:30 am - 5:00 PM
International Blvd. Foyer
ACR Clinical Symposium
7:30 - 8:30 am
Hall A3
Rheumatology Roundup: Highlights from the 2010
Annual Scientific Meeting c/r cP
Speakers: John J. Cush, MD; Baylor Research Institute; Dallas, TX
Arthur Kavanaugh, MD; University of California-San Diego; La
Jolla, CA
Session Overview:
This session is intended to be an informative overview and
will help attendees summarize the most interesting, novel,
significant abstracts that were presented during the 2010 annual
meeting. The session is presented by two rheumatologists,
highlighting their respective subjective opinions.
Upon completion of this session, participants should be able to:
• list research highlights from the scientific presentations
• discuss the clinical impact of selected research reports
presented at the meeting
• evaluate the therapeutic potential of selected clinical trials
presented at the meeting
ACR Immunology Updates for
Clinicians
7:30 - 8:30 am
B402
Therapeutic Use of Mesenchymal Stem Cells in
Rheumatologic Diseases c/r
Moderator: Richard J. Looney, MD; University of Rochester;
Rochester, NY
Speaker: Christian Jorgensen, MD, PhD; Hospital Lapeyronie;
Montpellier, France
Session Overview:
Mesenchymal stem cells have the capacity to differentiate
into multiple cell types including chondrocytes, osteoblasts,
adipocytes, myocytes, and fibroblasts. Surprisingly, in
experimental models mesenchymal stem cells have also been
found to ameliorate inflammation, improve angiogenesis, and
prevent fibrosis. Mesenchymal stem cells can be isolated from
bone marrow or fat and can be easily expanded in vitro. There
are now approximately 100 clinical trials using mesenchymal
stem cells including trials for Sjögren’s syndrome, systemic
sclerosis, and lupus nephritis.
Upon completion of this session, participants should be able to:
• describe the phenotype, distribution, isolation, and in vitro
culture of mesenchymal stem cells
• discuss how mesenchymal stem cells have been used in
animal models of human disease
• explain how mesenchymal stem cells are being tested as
therapy for human rheumatologic disease
ACR Practice Issues
7:30 - 8:30 am
B406
ICD -10 Preparation - Developing a Blueprint for
Implementation BR cP
Moderators: Christopher L. Colglazier, MD; Kunath, Burte and
Temming MD; Cincinnati, OH
Raymond Hong, MD, MBA; Ohio Permanente Medical Group;
Richfield, OH
Speaker: Gloryanne Bryant, BS, RHIA, RHIT, CCS; Kaiser
Foundation Health Plan Inc. and Hospitals; Oakland, CA
Session Overview:
The Department of Health and Human Services announced the
date of October 1, 2013 for ICD-10-CM implementation. ICD-10
implementation will ripple across many departments in health
care organizations including health information management,
coding, revenue cycle, billing and patient financial services. ICD-
10 will also stretch into the information technology department,
where software and hardware upgrades and solutions will be
needed to manage the new codes. Medical staff leadership
needs to be on board to help reinforce the physician and
clinical documentation changes required to ensure accurate
coding, billing and reimbursement. It is necessary to have an
implementation plan established and begun well in advance to
ensure a successful transition to ICD-10-CM and ICD-10-PCS. A
key to successful planning is the timeliness of training and other
activities. It is important for physicians to establish reasonable
plan to prepare themselves and their staff.
Upon completion of this session, participants should be able to:
• identify the basic variances between ICD-9-CM and ICD-10
• discuss how to locate the necessary resources and information
that is important for physician practices to transition to ICD-10
• identify an appropriate impact assessment plan
ACR State-of-the-Art Lectures
7:30 - 8:30 am
B313
Clinical Review: New Insights into Primary Central
Nervous System Vasculitis in Children P
Moderator: Kathleen M. O’Neil, MD; Oklahoma University
Health Science Center; Oklahoma City, OK
Speaker: Susanne M. Benseler, MD, PhD; The Hospital for Sick
Children; Toronto, ON, Canada
Session Overview:
Among the most perplexing and potentially devastating diseases
faced by rheumatologists are the inflammatory diseases of the
central nervous system. Collaborative work among neurologists
and rheumatologists, radiology and pathology have helped
identify subsets of children with primary central nervous system
vasculitis with differing clinical presentation and diagnostic
findings that impact how one approaches and treats these
extremely ill children.
2010 Program Book 133
thursday